代谢综合征通过ROS-miR-193b-NFYA通路下调可溶性鸟苷酸环化酶并导致射血分数保留心衰运动诱导肺动脉高压
该研究在肥胖ZSF-1大鼠(HFpEF模型)及SU5416处理的肥胖ZSF-1大鼠(CpcPH模型)中,发现代谢综合征通过增加活性氧和miR-193b表达,抑制NFYA依赖的sGCβ1表达,导致肺动脉血管功能障碍和运动诱导肺动脉高压。过表达NFYA或使用SGLT2抑制剂恩格列净可恢复NFYA-sGCβ1-cGMP信号并改善EIPH。
要点
- 代谢综合征通过ROS-miR-193b-NFYA轴下调sGCβ1,参与HFpEF相关EIPH。
- AAV6介导NFYA过表达可改善肥胖+sugen大鼠的运动肺动脉高压。
- 恩格列净改善代谢综合征、降低ROS和miR-193b、恢复sGC活性并预防EIPH。
核心结论
- 在HFpEF和CpcPH模型中,代谢综合征通过增强ROS和miR-193b表达下调NFYA依赖的sGCβ1表达,导致肺血管功能障碍和EIPH。
- AAV介导的NFYA过表达和SGLT2抑制可恢复NFYA-sGCβ1-cGMP信号并改善EIPH。
研究设计与样本
- 使用肥胖ZSF-1瘦素受体敲除大鼠(HFpEF模型)、肥胖ZSF-1大鼠加SU5416(肥胖+sugen,CpcPH模型)及瘦ZSF-1大鼠(对照)。
- 通过植入导管在跑步机运动时评估左右心室血流动力学,用磁共振成像和肌动描记法评估肺动脉功能。
主要发现
- 肥胖大鼠静息右心室收缩压正常,运动时显著升高,模拟EIPH;肥胖+sugen大鼠出现肺动脉解剖重构和静息右心室收缩压升高,运动时加重,模拟CpcPH。
- 多巴酚丁胺负荷下肌动描记法和磁共振成像显示两组肥胖大鼠均存在肺动脉功能受损。
- 肥胖大鼠肺动脉产生ROS并降低sGCβ1表达。
- 来自肥胖大鼠及糖尿病或经棕榈酸、葡萄糖和胰岛素处理的人肺动脉平滑肌细胞显示线粒体ROS增加,增强miR-193b依赖的NFYA RNA降解,导致sGCβ1-cGMP信号降低。
- AAV6递送强制表达NFYA增加sGCβ1水平并改善肥胖+sugen大鼠的运动肺动脉高压。
临床怎么用
- 对于HFpEF合并代谢综合征的患者,EIPH和CpcPH可能由ROS-miR-193b-NFYA-sGCβ1通路介导,SGLT2抑制剂恩格列净可能通过该机制获益。
- NFYA过表达或SGLT2抑制恢复sGCβ1-cGMP信号,为EIPH和CpcPH提供了潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many patients with heart failure with preserved ejection fraction have metabolic syndrome and develop exercise-induced pulmonary hypertension (EIPH). Increases in pulmonary vascular resistance in patients with heart failure with preserved ejection fraction portend a poor prognosis; this phenotype is referred to as combined precapillary and postcapillary pulmonary hypertension (CpcPH). Therapeutic trials for EIPH and CpcPH have been disappointing, suggesting the need for strategies that target upstream mechanisms of disease. This work reports novel rat EIPH models and mechanisms of pulmonary vascular dysfunction centered around the transcriptional repression of the soluble guanylate cyclase (sGC) enzyme in pulmonary artery (PA) smooth muscle cells. METHODS: We used obese ZSF-1 leptin-receptor knockout rats (heart failure with preserved ejection fraction model), obese ZSF-1 rats treated with SU5416 to stimulate resting pulmonary hypertension (obese+sugen, CpcPH model), and lean ZSF-1 rats (controls). Right and left ventricular hemodynamics were evaluated using implanted catheters during treadmill exercise. PA function was evaluated with magnetic resonance imaging and myography. Overexpression of nuclear factor Y α subunit (NFYA), a transcriptional enhancer of sGC β1 subunit (sGCβ1), was performed by PA delivery of adeno-associated virus 6. Treatment groups received the SGLT2 inhibitor empagliflozin in drinking water. PA smooth muscle cells from rats and humans were cultured with palmitic acid, glucose, and insulin to induce metabolic stress. RESULTS: Obese rats showed normal resting right ventricular systolic pressures, which significantly increased during exercise, modeling EIPH. Obese+sugen rats showed anatomic PA remodeling and developed elevated right ventricular systolic pressure at rest, which was exacerbated with exercise, modeling CpcPH. Myography and magnetic resonance imaging during dobutamine challenge revealed PA functional impairment of both obese groups. PAs of obese rats produced reactive oxygen species and decreased sGCβ1 expression. Mechanistically, cultured PA smooth muscle cells from obese rats and humans with diabetes or treated with palmitic acid, glucose, and insulin showed increased mitochondrial reactive oxygen species, which enhanced miR-193b-dependent RNA degradation of nuclear factor Y α subunit (NFYA), resulting in decreased sGCβ1-cGMP signaling. Forced NYFA expression by adeno-associated virus 6 delivery increased sGCβ1 levels and improved exercise pulmonary hypertension in obese+sugen rats. Treatment of obese+sugen rats with empagliflozin improved metabolic syndrome, reduced mitochondrial reactive oxygen species and miR-193b levels, restored NFYA/sGC activity, and prevented EIPH. CONCLUSIONS: In heart failure with preserved ejection fraction and CpcPH models, metabolic syndrome contributes to pulmonary vascular dysfunction and EIPH through enhanced reactive oxygen species and miR-193b expression, which downregulates NFYA-dependent sGCβ1 expression. Adeno-associated virus-mediated NFYA overexpression and SGLT2 inhibition restore NFYA-sGCβ1-cGMP signaling and ameliorate EIPH.
引用
- Satoh T, Wang L, Espinosa-Diez C, et al. Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Downregulation of Soluble Guanylate Cyclase and Contributes to Exercise-Induced Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction. Circulation. 2021. PMID: 34157861. doi:10.1161/CIRCULATIONAHA.121.053889
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。